Clinical Trial Application for global Phase 3 trials with nizubaglustat in GM1/GM2 gangliosidoses and Niemann-Pick Disease Type C approved in multiple European countries, anticipated to begin in Q2, ...
In a move cited to provide a more comprehensive product and service offering, Japanese PV equipment supplier NPC has merged its Germany-based subsidiaries, NPC Europe and Meier Solar Solutions. The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results